The renin-angiotensin-aldosterone system (RAAS) plays a vital role in regulating blood pressure, fluid volume, and sodium levels. RAAS inhibitors are indicated in patients with kidney disease as they prevent proteinuria, kidney fibrosis, and slow the decline of renal function. However, they are also associated with several adverse effects and require crucial monitoring while the therapy is indicated. Docplexus has organized an interactive webinar on “R isk Vs Benefit: RAAS Inhibitors in Patients with Kidney Disease” on 10th June 2021, 3:00 pm onwards .
In this webinar, Dr. Vipul Kapoor and Dr. Anish Chandarana will share their insights on the appropriate use of RAAS inhibitors in treating kidney disease and the changes in the guideline for the management of hypertension. We invite you to share your questions which will be answered at the end of the session.
